As shown in Figs. 2 and 3, diallyl trisulfide causes an increase in Bcl-2 inactivated in U87MG and SH-SY5Y cells; the active form of Bcl-2 is decreased in both cancer cell lines. Here, BCL2 is linked to cancer.